Merck KGaA (OTCMKTS:MKKGY) Short Interest Up 1,742.9% in October

Merck KGaA (OTCMKTS:MKKGYGet Free Report) saw a significant growth in short interest in October. As of October 31st, there was short interest totalling 12,900 shares, a growth of 1,742.9% from the October 15th total of 700 shares. Based on an average daily trading volume, of 88,800 shares, the short-interest ratio is presently 0.1 days.

Analyst Upgrades and Downgrades

Separately, The Goldman Sachs Group began coverage on Merck KGaA in a research report on Thursday, September 19th. They issued a “buy” rating on the stock.

View Our Latest Report on MKKGY

Merck KGaA Price Performance

Shares of MKKGY stock traded down $0.07 on Wednesday, reaching $32.05. The company’s stock had a trading volume of 80,516 shares, compared to its average volume of 66,111. The stock’s 50 day simple moving average is $34.85 and its 200-day simple moving average is $35.15. Merck KGaA has a 12-month low of $28.98 and a 12-month high of $39.17. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The company has a market capitalization of $20.71 billion, a P/E ratio of 22.65, a PEG ratio of 2.40 and a beta of 0.96.

Merck KGaA Company Profile

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

Featured Stories

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.